oligonucleotides Latest News

Bio-Synthesis is able to synthesize ultra long oligonucleotides (RNA and DNA).

TIDES Organisers Recognise Link Technologies’ Expertise in the Diagnostic Applications of Nucleotides

AnaSpec is pleased to highlight our wide collection of amine and thiol reactive 6-isomeric dyes of fluoresceins and rhodamines, and AnaSpec’s own proprietary HiLyte Fluor™ dyes for labeling amine and thiol modified oligonucleotides.

Antigene therapy is a promising new treatment strategy that uses a DNA-based drug to pinpoint light energy to a target gene shutting down its activity. A review article published online ahead of print in Oligonucleotides.

TriLink BioTechnologies, Inc. (TriLink), a key manufacturer of high quality oligonucleotides and nucleoside triphosphates, announced the launch of its new website and OligoBuilder® online oligonucleotide ordering system.

TriLink BioTechnologies, has entered into an agreement with Cedarlane Corporation, a Canadian based research biotechnology company, for sale and distribution of its modified nucleoside triphosphates, custom chemistry and oligonucleotide products.

A novel class of drugs composed of single strands of DNA or RNA, called aptamers, can bind protein targets with a high strength and specificity and are currently in clinical development as treatments for a broad range of common diseases

Small synthetic fragments of genetic material called small interfering RNA (siRNA) can block production of abnormal proteins; however, these exciting new drug candidates can also induce a strong immune response, causing toxic side effects